A Randomized Controlled Trial to Evaluate the Safety and Efficacy of an Oral Supplement in Supporting Vision and Eye Health
NCT07123584 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60
Last updated 2025-08-14
Summary
This is a 4-week virtual randomized, triple-blinded, placebo-controlled clinical trial evaluating the safety and efficacy of Eye Empower, an oral supplement, in adults aged 45 or older experiencing dry eyes, irritation, and fatigue. Participants take 3 capsules daily and complete self-reported eye health questionnaires weekly.
Conditions
- Dry Eye
- Eye Fatigue
Interventions
- DIETARY_SUPPLEMENT
-
Eye Empower
A multi-ingredient oral supplement formulated to support eye health. Daily dose (3 capsules).
- DIETARY_SUPPLEMENT
-
Placebo
Identical gelatin capsules filled with inert rice flour, administered in the same dosage (3 capsules daily).
Sponsors & Collaborators
-
Citruslabs
collaborator INDUSTRY -
Bio Nature Health
lead INDUSTRY
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- TRIPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 45 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2024-11-06
- Primary Completion
- 2024-12-30
- Completion
- 2024-12-30
Countries
- United States
Study Locations
More Related Trials
-
Study of the Safety and Efficacy of OmegaD Softgels in the Treatment of Dry Eye Disease
NCT02980224 ·Status: COMPLETED ·Phase: PHASE3
-
Study of Application of Pulse Electrical Stimulation Around Eye in Dry Eye Disease Patients Who Are Scheduled for Laser Epithelial Keratomileusis (LASEK) Surgery
NCT06120348 ·Status: RECRUITING ·Phase: NA
-
Study of INS365 Ophthalmic Solution in Subjects With Dry Eye Disease
NCT00403715 ·Status: COMPLETED ·Phase: PHASE3
-
The Effects of Dietary Supplementation With Omega-3 Fatty Acids on Symptoms of Dry Eye
NCT03141931 ·Status: COMPLETED ·Phase: NA
-
Study of INS365 Ophthalmic Solution in Subjects With Dry Eye Disease
NCT00404131 ·Status: COMPLETED ·Phase: PHASE3
-
Effect of a Dietary Supplement on Gut Microbiota and Ocular Surface Outcomes in Dry Eye Disease
NCT07148271 ·Status: COMPLETED ·Phase: NA
-
The TRANQUILITY Trial: Clinical Trial to Assess the Efficacy and Safety in Subjects With Dry Eye Disease
NCT04674358 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Study of OT202 in Treating Moderate to Severe Dry Eye
NCT06435182 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy of OC-01 Nasal Spray on Goblet Cell and Meibomian Gland Stimulation
NCT03688802 ·Status: COMPLETED ·Phase: PHASE2
-
Eyelid Androgen Treatment in Dry Eye
NCT06154200 ·Status: COMPLETED ·Phase: PHASE2
-
Prospective Evaluation of Efficacy and Safety of an Intense Pulsed Light Device to Treat Dry Eye Disease"
NCT06349356 ·Status: COMPLETED ·Phase: NA
-
Probiotic in Dry Eye Syndromes
NCT04938908 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Efficacy of BRM421 for Dry Eye Syndrome Treatment
NCT04343287 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Phase 3 Study of the Safety and Efficacy of OmegaD Softgels in the Treatment of Dry Eye Disease
NCT04181593 ·Status: COMPLETED ·Phase: PHASE3
-
Study of INS365 Ophthalmic Solution in a Controlled Adverse Environment in Patients With Dry Eye
NCT00037661 ·Status: COMPLETED ·Phase: PHASE3
-
Clinical Study to Investigate the Efficacy and Safety of Orally Administered SA001 in Patients With Dry Eye Syndrome.
NCT03723798 ·Status: COMPLETED ·Phase: PHASE2
-
Intense Pulse Light Treatment With Meibomian Gland Expression of the Upper Eyelids in Dry Eye Disease
NCT03658811 ·Status: COMPLETED ·Phase: NA
-
Efficacy and Safety of BUFY02 Versus TRB02 in the Treatment of Dry Eye Disease
NCT05865457 ·Status: RECRUITING ·Phase: NA
-
Safety and Efficacy of Licaminlimab Ophthalmic Solution for the Treatment of Dry Eye Disease
NCT05896670 ·Status: COMPLETED ·Phase: PHASE2
-
Study of the TearCare System in Dry Eye Disease
NCT03588624 ·Status: COMPLETED ·Phase: NA
-
A Study Evaluating the Efficacy and Safety of RCI001 Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye
NCT07068958 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Dry Eye Assessment and Management Study
NCT02128763 ·Status: COMPLETED ·Phase: PHASE3
-
Study to Evaluate the Safety, Tolerability, and Efficacy of OTX-CSI in Subjects With Dry Eye Disease.
NCT04362670 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Treatment of Dry Eye Disease Using Pro-ocular™ - A Proof of Concept, Safety, and Efficacy Study
NCT04884217 ·Status: UNKNOWN ·Phase: PHASE2
-
Efficacy and Safety of BUFY01 Versus SVS20 in the Treatment of Dry Eye Disease
NCT05865379 ·Status: RECRUITING ·Phase: NA